What it is (overview)

The Hepatitis B Antibodies blood test checks for antibodies your immune system may have made in response to the Hepatitis B virus (HBV) or the Hepatitis B vaccine. Antibodies are protective proteins that can remain in the blood after an infection has resolved or after vaccination. This test is an important part of Hepatitis B screening and helps evaluate liver health and immunity.

Hepatitis B antibody testing most commonly includes one or more of the following markers:

• Anti-HBs (Hepatitis B surface antibody): This is the key marker of immunity. A positive anti-HBs usually means you are protected against Hepatitis B—either because you were successfully vaccinated or because you recovered from a past HBV infection.

• Anti-HBc (Hepatitis B core antibody): This typically indicates past or current natural infection (it is not produced from vaccination). It may be reported as total anti-HBc (IgG + IgM) or broken out into IgM anti-HBc to help identify recent infection.

In plain language, results often mean:

• Immune from vaccination: Anti-HBs positive, anti-HBc negative.

• Immune due to past infection (recovered): Anti-HBs positive, anti-HBc positive.

• Possible current infection: Antibody patterns plus other HBV tests (especially HBsAg and sometimes HBV DNA) are used to confirm whether infection is current and whether it is acute or chronic.

• Not immune / susceptible: Anti-HBs negative and anti-HBc negative—this often means you are not protected and may benefit from vaccination.

Because antibody patterns can be complex (for example, “isolated anti-HBc positive” can have multiple explanations), clinicians often order Hepatitis B antibodies alongside other diagnostics such as HBsAg (surface antigen) and HBV DNA viral load for a complete picture.

When & why it's usually done

A doctor may order Hepatitis B antibodies testing as part of routine screening, to check vaccine response, or to evaluate possible viral hepatitis. It is commonly done when someone has symptoms, abnormal liver tests, known exposure risk, or belongs to a group at higher risk for HBV.

Common reasons to test include:

• Screening with no symptoms: Many people with Hepatitis B have no symptoms for years. Screening helps detect silent infection and prevent complications or transmission.

• Symptoms that may suggest hepatitis or liver inflammation: Fatigue, nausea, poor appetite, abdominal discomfort (especially right upper abdomen), dark urine, pale stools, joint aches, or jaundice (yellowing of skin/eyes).

• Abnormal liver blood tests: Elevated ALT/AST or other markers of liver injury may prompt hepatitis testing.

• After possible exposure: Unprotected sex with a new partner, household contact with someone who has HBV, needlestick injury, sharing needles/syringes, or other blood-to-blood exposure.

• Pregnancy and prenatal care: Screening helps protect the baby and guides prevention steps if the mother has current infection or is not immune.

• Before starting certain medications or treatments: People who will receive immunosuppressive therapy (e.g., chemotherapy, biologic agents, high-dose steroids) are often tested because HBV can reactivate.

• Checking immunity and vaccine effectiveness: Testing can confirm whether vaccination produced protective antibodies, especially in healthcare workers, dialysis patients, people with weakened immune systems, or after a vaccination series.

• Ongoing monitoring in people at risk: Individuals with chronic liver disease, HIV infection, or those with ongoing exposure risks may need periodic testing as part of preventive care.

Common diseases related to it

• Acute Hepatitis B infection
• Chronic Hepatitis B infection (chronic HBV)
• Resolved (past) Hepatitis B infection with immunity
• Hepatitis B vaccine-related immunity (protective antibody response)
• Hepatitis B reactivation (especially during immunosuppression)
• HBV-related liver inflammation (hepatitis) and elevated liver enzymes
• Cirrhosis (scarring of the liver) due to chronic Hepatitis B
• Hepatocellular carcinoma (primary liver cancer) linked to chronic HBV

Health goals where it may help

• Hepatitis B screening and early detection of viral infection
• Confirming immunity after Hepatitis B vaccination (vaccine effectiveness)
• Protecting liver health by identifying chronic HBV risk and guiding follow-up care
• Reducing transmission risk to partners, household members, and newborns (prenatal prevention)
• Pre-treatment safety checks before chemotherapy, biologics, or other immunosuppressive medications
• Monitoring people with ongoing exposure risk (e.g., healthcare exposure, needle exposure)
• Supporting long-term prevention of complications such as cirrhosis and liver cancer through timely diagnosis and management